LATEST PSYCHEDELICS STOCKS NEWS

51 views6 min read

Lobe Sciences Ltd. Announces That The Drug Enforcement Administration Has Issued The Initial 2023 Quota Allowing Export Of L-130

Lobe Sciences
Dosing In Human Clinical Trial To Commence Within WeeksVancouver, British Columbia--(Newsfile Corp. - March 22, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe"), a North American Biopharmaceutical company committed to discovering and developing patient-focused medicines for Orphan and Rare diseases today announced that its e... Read More...
Calendar154 views2 min read

Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Numinus Wellness
VANCOUVER, BC, March 22, 2023 - Numinus Wellness Inc.Β ("Numinus") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in the Sequire Cannabis & Psychedelics Conference to be held virtually on Wednesday... Read More...
Calendar186 views5 min read

Red Light Holland Looking Forward to AGSM, Including Corporate Update from Chairman Brad J Lamb and a Live Q&A With CEO Todd Shapiro on March 23rd at 11 AM

Red Light Holland
Brad J Lamb, Red Light Holland's Chairman of the Board will Chair the AGSM, which takes place at 11 am EST on March 23, 2023CEO Todd Shapiro, CTIO Sarah Hashkes and CFO David Ascott of Red Light Holland will conduct a live Q&A immediately after the AGSMThe AGSM will take place in person at the offices of the Company located at 1 Adela... Read More...
44 views7 min read

Red Light Holland Announces Distribution Agreement With New Zealand Based NUBU Pharmaceuticals To Explore Legal Import and Distribution Of Psilocybin Microdosing Capsules To Australasia

Red Light Holland
Toronto, Ontario--(Newsfile Corp. - March 13, 2023) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland"), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand of psilocybin truffles to the legal, recreationa... Read More...
113 views5 min read

Revive Therapeutics Provides Update From Type C Meeting with FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Revive Therapeutics
<!-- Name:DistributionId Value:8784103 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 --> <!-- Name:CustomerId Value:1105448 --> <!-- Name:HasMediaSnippet Value:false --> <!-- Name:AnalyticsTrackingId Value:863e347a-d4b8-40b3-aef2-cadd80329520 --> FDA recommends... Read More...
1327 views5 min read

BetterLife Announces Offering of Units

BetterLife Pharma
<!-- Name:DistributionId Value:8783646 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 --> <!-- Name:CustomerId Value:1216524 --> <!-- Name:HasMediaSnippet Value:false --> <!-- Name:AnalyticsTrackingId Value:2b7cca25-ad23-435f-b4ab-5d49209e3a38 --> NOT FOR DISTRI... Read More...
41 views8 min read

Red Light Holland’s Psilocybin Truffles Arrive Successfully in Canada, Under a Health Canada Approved Psilocybin Import Permit to CCrest Labs, Beginning Development of Microdosing Capsules

Red Light Holland
Red Light Holland safely exports another 3000 Grams (3KG) of Psilocybin Truffles, produced and sold in The Netherlands, into Canada under a fourth Health Canada approved psilocybin import permit to its laboratory partner, CCrest Laboratories Inc., a cGMP pharmaceutical laboratory in Montreal, CanadaCCrest Labs to utilize its newly amended... Read More...
872 views9 min read

Optimi Health Enters Australian Medical MDMA And Psilocybin Market With Mind Medicine Australia Distribution Agreement

Optimi Health
Optimi Health Corp.The announcement follows a national reclassification of MDMA and psilocybin for therapeutic uses in Australia as a result of the years-long effort of Mind Medicine Australia and its dedicated supportersHighlights:Β Signed Purchase Orders with Mind Medicine Australia to ensure that patients with treatment resistant post-t... Read More...
1096 views8 min read

Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

Bright Minds Biosciences
Bright Minds Biosciences-- First-in-human Phase 1 trial for lead program, BMB-101, a highly selective 5-HT2C agonist, is underway in Australia ---- Company has transitioned from a discovery to a development organization –-- Company to attend BIO-Europe Spring Conference in Basel, Switzerland, March 20-22, 2023 --VANCOUVER, British Columbi... Read More...
476 views8 min read

Cybin Announces Positive Data from its CYB003 Phase 1/2a Trial and Provides Update on its CYB004 Development Program

Cybin
- CYB003 Phase 1/2a interim data demonstrate rapid and short-acting effects; robust psychedelic effects at low doses; positive safety and tolerability profile; top-line efficacy data expected late Q3 2023 -- Initial findings from Phase 1 CYB004-E study suggest IV DMT was well-tolerated; study design expanded to accelerate first-in-human d... Read More...
48 views0 min read

Algernon Pharmaceuticals subsidiary completes first dosing in Phase 1 clinical study of DMT

Algernon Pharmaceuticals
Vancouver --News Direct-- Algernon Pharmaceuticals Inc.Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to share news the company’s subsidiary Algernon NeuroScience has announced it has completed the first dosing in its Phase 1 clinical study of an intravenous formulation of AP-188 or DMT.Moreau told Pro... Read More...
Calendar24 views3 min read

Numinus to Participate in a Water Tower Research Fireside Chat on Tuesday, February 28, 2023

Numinus Wellness
VANCOUVER, BC, Feb. 24, 2023 - Numinus Wellness Inc.Β ("Numinus") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Dr. Paul Thielking, Chief Science OfficerΒ of Numinus, will participate in a Water Tower Research Fireside Ch... Read More...
CalendarFinancials1112 views10 min read

Cybin Inc. Reports Third Quarter Financial Results and Recent Business Highlights

Cybin
- Company to provide CYB003 Phase 1/2a interim study readout and update on its CYB004 program at upcoming R&D Day on February 28, 2023 -This news release constitutes a "designated news release" for the purposes of Cybin’s prospectus supplement dated August 8, 2022 to its short form base shelf prospectus dated July 5, 2021TORONTO, Febr... Read More...
857 views4 min read

Lobe Sciences, Ltd. Announces USD$250,000 Convertible Note Financing and Warrant Issuance

Lobe Sciences
Vancouver, British Columbia--(Newsfile Corp. - February 10, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe"), a North American Biopharmaceutical company committed to discovering and developing patient-focused psychedelic-derived medicines for neurologic and brain disease today announced a financing in the amount of USD $250,... Read More...
876 views3 min read

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements

Bright Minds Biosciences
<!-- Name:DistributionId Value:8745619 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 --> <!-- Name:CustomerId Value:1215554 --> <!-- Name:HasMediaSnippet Value:false --> <!-- Name:AnalyticsTrackingId Value:15d9ac77-e32d-4c3e-8cc8-486c808a7e18 --> VANCOUVER, Bri... Read More...
1241 views5 min read

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

Creso Pharma
The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditionsNEDLANDS, Australia, Feb. 8, 2023 --Β Creso Pharma LimitedΒ (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Scie... Read More...
28 views5 min read

Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development

Revive Therapeutics
Revive Therapeutics Ltd.TORONTO, Feb. 06, 2023 -- Revive Therapeutics Ltd. (β€œRevive” or the β€œCompany”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into a supply agreement wit... Read More...
75 views0 min read

Algernon Pharmaceuticals subsidiary Algernon NeuroScience doses first patient in stroke study

Algernon Pharmaceuticals
Vancouver, BC --News Direct-- Algernon Pharmaceuticals Inc.Algernon Pharmaceuticals CEO Christopher Moreau said the company has announced that its subsidiary Algernon NeuroScience has dosed the first subject in the Phase 1 DMT clinical stroke study. Moreau told Proactive this dosing was in the Netherlands where the study is being conducte... Read More...
418 views7 min read

Numinus Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea

Numinus Wellness
Clinical trial will be the first to test whole PsilocybeΒ mushrooms for safety and efficacy in a clinical setting; study is expected to provide important data to support increased access to psilocybin-assisted therapy. Clinical trial will provide experiential training to therapists learning to conduct psilocybin-assisted therapy and will ... Read More...
43 views2 min read

Silo Pharma Announces Stock Repurchase Program

Silo Pharma
<!-- Name:DistributionId Value:8739407 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:3763 --> <!-- Name:CustomerId Value:500069339 --> <!-- Name:HasMediaSnippet Value:false --> <!-- Name:AnalyticsTrackingId Value:70b89588-316b-4a04-8242-c80c78044f63 --> ENGLEWOOD CL... Read More...
M & A385 views11 min read

Red Light Holland Updates Acquisition and Development of 100 Acres of Farmland in Ontario, Canada Expanding Its Mushroom Farms Division in North America

Red Light Holland
Through experienced partners, Red Light's Farm Division plans on growing mushroom production with projected additional 65,000 sq feet of "Innovative and Unique" mushroom production facilitiesRed Light Holland is currently working with an expert mushroom design firm in The Netherlands and experienced Canadian engineersPlans are expected to... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!